Derivative exercise or conversion — not an open-market buy.
Loading…
Traded May 18, 2026 · Filed May 20, 2026
A board member of Collegium Pharmaceutical sold $681 of Collegium Pharmaceutical shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$681
Shares × reported transaction price
11 days after results of May 7, 2026, 80 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.0% | +1.6% | −4.7% |
| 30 days | −2.8% | +0.2% | −3.0% |
| 90 days | −16.5% | +3.5% | −20.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.